View of TEN-YEAR KETOGENIC DIET AS PRIMARY THERAPY IN SCN2A-RELATED DRUG-RESISTANT DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY: LONG-TERM EFFICACY, SAFETY, AND MULTISYSTEM OUTCOMES

Return to Article Details TEN-YEAR KETOGENIC DIET AS PRIMARY THERAPY IN SCN2A-RELATED DRUG-RESISTANT DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY: LONG-TERM EFFICACY, SAFETY, AND MULTISYSTEM OUTCOMES Download Download PDF